We wish to inform you about the financial assistance of the participating companies according to their membership in FSA e.V. (Association for Voluntary Self-Control of the Pharmaceutical Industry), AKG e.V. (Association for Medicinal Products and Cooperation in the Health Sector) or because the companies have approved the publication.
Regardless of the above-mentioned memberships, the conditions and scope of financial assistance of all companies as well as specialist publishers who support the event will be published, if this is stipulated by the professional codes of the respective regional medical associations.
Moreover, this complies with the recommendations of the Federal Medical Association (Bundesärztekammer) on continuing medical education, 4th revised edition, last updated: 24 April 2015, p.11 et seq., section 32 para. (3) of the (Model) Professional Code for Physicians in Germany ((Muster-)Berufsordnung für die in Deutschland tätigen Ärztinnen und Ärzte – MBO), section 8 para. (1) no. 3 of the (Model) Continuing Medical Education Code (Musterfortbildungsordnung – MFO).
The content of this event is designed to be product- and service-neutral. We confirm that the scientific management and the speakers will disclose potential conflicts of interest to the participants. The following companies are sponsors:
Abbott Medical GmbH 9.000,00 EUR; Angiodroid SpA 4.000,00 EUR; Artivion EMEA GmbH 10.000,00 EUR;Asanus Medizintechnik GmbH 4.000,00 EUR; BD Becton Dickinson GmbH 10.000,00 EUR; Bentley InnoMed GmbH 6.000,00 EUR; Boston Scientific Medizintechnik GmbH 10.000,00 EUR; Brainlab AG 4.000,00 EUR; Cook Medical 6.000,00 EUR; Endologix International Holdings B.V. 4.100,00 EUR; Geister Medizintechnik GmbH 2.000,00 EUR; Getinge Deutschland GmbH 2.500,00 EUR; Gore Medical GmbH 12.000,00 EUR; Inari Medical Europe GmbH 8.000,00 EUR; InnoRa CRO GmbH 8.000,00 EUR; iVascular GmbH 3.000,00 EUR; Lombard Medical Technologies GmbH 4.000,00 EUR; Medistim ASA 8.000,00 EUR; Medtronic GmbH 25.000,00 EUR; Merit Medical GmbH 4.000,00 EUR; Mylan Germany GmbH (a Viatris Company) 4.000,00 EUR; NXT MED GmbH 2.500,00 EUR; Optimed Medizinische Instrumente GmbH 4.000,00 EUR; Penumbra Europe GmbH 4.oo0,00 EUR; Philips Market DACH Healthcare 4.000,00 EUR; Reflow Medical Europe GmbH 2.000,00 EUR; shape memory medical 6.000,00 EUR; Shockwave Medical Inc. 7.000,00 EUR; SVP Medical GmbH in Kooperation mit Strätz fn Medizintechnik 2.500,00 EUR; Terumo Deutschland GmbH 2.500,00 EUR; Vascutek Deutschland GmbH t/a Terumo Aortic 17.500,00 EUR; Veryan Medical GmbH 3.500,00 EUR; Ziehm Imaging GmbH 4.000,00 EUR
The total expenses amount to 257.037,00 EUR.
